Immunisation with canarypox virus expressing rabies glycoprotein
- 13 June 1992
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 339 (8807), 1429-1432
- https://doi.org/10.1016/0140-6736(92)92027-d
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Potential use of non-replicating vectors as recombinant vaccinesVaccine, 1992
- Large-scale eradication of rabies using recombinant vaccinia-rabies vaccineNature, 1991
- Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virusVaccine, 1991
- Efficacy studies on a canarypox-rabies recombinant virusVaccine, 1991
- Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinThe Lancet, 1991
- Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitisVaccine, 1990
- Recombinant fowlpox virus inducing protective immunity in non-avian speciesVaccine, 1988
- Fowlpox virus as a vector in non-avian speciesVaccine, 1988
- Protective immunity against avian influenza induced by a fowlpox virus recombinantVaccine, 1988
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984